| Definitive Healthcare Corp. (DH) Q1 2025 Earnings Call Transcript |
Definitive Healthcare Corp. (NASDAQ:DH ) Q1 2025 - Earnings Conference Call May 8, 2025 5:00 PM ET Company Participants Matthew Ruderman - Investor Relations Kevin Coop - CEO Rick Booth - CFO Casey Heller - SVP, Finance Conference Call Participants Jared Haase - William Blair Craig Hettenbach - Morgan Stanley David Grossman - Stifel George Hill - Deutsche Bank Jenny Shen - BTIG Operator Welcome to Definitive Healthcare's Q1 2025 Earnings Call. Later, we will conduct a question and answer session. |
seekingalpha.com |
2025-05-11 04:07:01 |
Czytaj oryginał (ang.) |
| Definitive Healthcare Corp. (DH) Beats Q1 Earnings and Revenue Estimates |
Definitive Healthcare Corp. (DH) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $0.08 per share a year ago. |
zacks.com |
2025-05-08 23:00:52 |
Czytaj oryginał (ang.) |
| Definitive Healthcare Reports Financial Results for First Quarter Fiscal Year 2025 |
FRAMINGHAM, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter ended March 31, 2025. |
globenewswire.com |
2025-05-08 20:05:00 |
Czytaj oryginał (ang.) |
| Definitive Healthcare Announces Timing of Its First Quarter 2025 Financial Results Conference Call and Webcast |
FRAMINGHAM, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its first quarter ended March 31, 2025, on Thursday, May 8, 2025 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company's financial results. |
globenewswire.com |
2025-04-24 20:05:00 |
Czytaj oryginał (ang.) |
| Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4) |
FRAMINGHAM, Mass., April 04, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that in connection with the hiring of one senior leader, the Human Capital Management and Compensation Committee (the “Committee”) of Definitive Healthcare's Board of Directors granted inducement awards. The Committee granted Jeff Moyer, Definitive Healthcare's new SVP of Growth and Sales Operations, an inducement award consisting of 364,432 time-based restricted stock units (“RSUs”), effective April 3, 2025. These awards were individually negotiated and granted as an inducement material to Mr. Moyer's respective commencement of employment with Definitive Healthcare in accordance with Nasdaq Listing Rule 5635(c)(4). |
globenewswire.com |
2025-04-04 12:00:00 |
Czytaj oryginał (ang.) |
| Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4) |
FRAMINGHAM, Mass., March 04, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that in connection with the hiring of two senior leaders, the Human Capital Management and Compensation Committee (the “Committee”) of Definitive Healthcare's Board of Directors granted inducement awards. The Committee granted Kate Hastings, Definitive Healthcare's new Chief Customer Officer an inducement award consisting of 172,414 time-based restricted stock units (“RSUs”) effective March 3, 2025 and granted Benjamin Graboske, Definitive Healthcare's new EVP, Technology, Engineering and Chief Data Officer an inducement award consisting of 1,018,330 time-based RSUs, effective March 3, 2025. Each of these awards was individually negotiated and was granted as an inducement material to Ms. Hastings' and Mr. Graboske's respective commencement of employment with Definitive Healthcare in accordance with Nasdaq Listing Rule 5635(c)(4). |
globenewswire.com |
2025-03-04 18:05:00 |
Czytaj oryginał (ang.) |
| New Strong Sell Stocks for March 4th |
Teaser: AMRC, DH and AAON have been added to the Zacks Rank #5 (Strong Sell) List on March 4, 2025. |
zacks.com |
2025-03-04 08:56:08 |
Czytaj oryginał (ang.) |
| Definitive Healthcare Corp. (DH) Q4 2024 Earnings Call Transcript |
Definitive Healthcare Corp. (NASDAQ:DH ) Q4 2024 Results Conference Call February 27, 2025 5:00 PM ET Company Participants Matthew Ruderman - Investor Relations Kevin Coop - Chief Executive Officer Rick Booth - Chief Financial Officer Conference Call Participants Jared Haase - William Blair Hanna Lee - Bank of America Jenny Shen - BTIG David Grossman - Stifel Maxi Ma - Deutsche Bank Johnathan McCary - Raymond James Craig Hettenbach - Morgan Stanley Jeff Garro - Stephens Operator Welcome to Definitive Healthcare's Q4 2024 Earnings Call. [Operator Instructions] I would like to now turn the call over to your host. |
seekingalpha.com |
2025-02-28 20:21:05 |
Czytaj oryginał (ang.) |
| Definitive Healthcare Corp. (DH) Q4 Earnings and Revenues Surpass Estimates |
Definitive Healthcare Corp. (DH) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of $0.07 per share. This compares to earnings of $0.07 per share a year ago. |
zacks.com |
2025-02-27 21:25:41 |
Czytaj oryginał (ang.) |
| Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2024 |
FRAMINGHAM, Mass., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter and full year ended December 31, 2024. |
globenewswire.com |
2025-02-27 18:05:00 |
Czytaj oryginał (ang.) |
| Definitive Healthcare to Present at the Raymond James 2025 Institutional Investors Conference |
FRAMINGHAM, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Chief Executive Officer, Kevin Coop, and its Chief Financial Officer, Rick Booth, will present at the Raymond James 2025 Institutional Investors Conference. |
globenewswire.com |
2025-02-25 18:05:00 |
Czytaj oryginał (ang.) |
| DH or FFIV: Which Is the Better Value Stock Right Now? |
Investors interested in stocks from the Internet - Software sector have probably already heard of Definitive Healthcare Corp. (DH) and F5 Networks (FFIV). But which of these two stocks presents investors with the better value opportunity right now? |
zacks.com |
2025-02-20 14:45:50 |
Czytaj oryginał (ang.) |
| Definitive Healthcare Announces Timing of Its Fourth Quarter and Full Year 2024 Financial Results Conference Call and Webcast |
FRAMINGHAM, Mass., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its fourth quarter and full year ended December 31, 2024, on Thursday, February 27, 2025 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company's financial results. |
globenewswire.com |
2025-02-13 18:05:00 |
Czytaj oryginał (ang.) |
| A Dive Into Definitive Healthcare |
Definitive Healthcare trades at a discount to the overall market based on P/E, and a new CEO with a focus on simplifying operations but faces declining profits and revenues. The company also has recently announced a new $100 billion stock buyback authorization and is seeing significant unlevered free cash flow. A first look at Definitive Healthcare follows in the paragraphs below. |
seekingalpha.com |
2025-02-04 12:01:04 |
Czytaj oryginał (ang.) |
| DH vs. FFIV: Which Stock Is the Better Value Option? |
Investors looking for stocks in the Internet - Software sector might want to consider either Definitive Healthcare Corp. (DH) or F5 Networks (FFIV). But which of these two companies is the best option for those looking for undervalued stocks? |
zacks.com |
2025-02-03 14:41:29 |
Czytaj oryginał (ang.) |
| Definitive Healthcare (DH) Surges 8.4%: Is This an Indication of Further Gains? |
Definitive Healthcare (DH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term. |
zacks.com |
2025-01-29 13:10:27 |
Czytaj oryginał (ang.) |
| Definitive Healthcare named a 2025 Best Places to Work in Boston by Built In |
FRAMINGHAM, Mass., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it has been named one of Built In's 100 Best Places to Work in Boston, MA for 2025. The annual awards program includes companies of all sizes, from startups to large enterprises, and honors both remote-first employers as well as companies in large tech markets across the U.S. |
globenewswire.com |
2025-01-29 11:46:00 |
Czytaj oryginał (ang.) |
| Definitive Healthcare (DH) Moves to Buy: Rationale Behind the Upgrade |
Definitive Healthcare (DH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. |
zacks.com |
2025-01-21 15:00:45 |
Czytaj oryginał (ang.) |
| Down -5.29% in 4 Weeks, Here's Why You Should You Buy the Dip in Definitive Healthcare (DH) |
Definitive Healthcare (DH) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock. |
zacks.com |
2025-01-21 12:36:13 |
Czytaj oryginał (ang.) |
| DH or PRVA: Which Is the Better Value Stock Right Now? |
Investors interested in Medical Info Systems stocks are likely familiar with Definitive Healthcare Corp. (DH) and Privia Health (PRVA). But which of these two companies is the best option for those looking for undervalued stocks? |
zacks.com |
2025-01-15 14:41:13 |
Czytaj oryginał (ang.) |
| Definitive Healthcare to Present at the 27th Annual Needham Growth Conference |
FRAMINGHAM, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Chief Executive Officer, Kevin Coop, and its Chief Financial Officer, Rick Booth, will present at the 27th Annual Needham Growth Conference. |
globenewswire.com |
2025-01-08 18:05:00 |
Czytaj oryginał (ang.) |
| DH vs. PRVA: Which Stock Is the Better Value Option? |
Investors with an interest in Medical Info Systems stocks have likely encountered both Definitive Healthcare Corp. (DH) and Privia Health (PRVA). But which of these two stocks presents investors with the better value opportunity right now? |
zacks.com |
2024-12-20 14:45:26 |
Czytaj oryginał (ang.) |
| Definitive Healthcare initiated with an Equal Weight at Stephens |
Stephens initiated coverage of Definitive Healthcare with an Equal Weight rating and $5 price target. Definitive has "an impressive collection of data assets that have attracted a marquee customer base," as well as a track record of expanding enterprise relationships, but this is all "still in early stages of coming together as a single, unified platform," the analyst tells investors. The firm thinks investors need to see multiple, firm data points supporting a return to growth before re-rating the stock higher from here, the analyst added. |
https://thefly.com |
2024-12-19 18:21:36 |
Czytaj oryginał (ang.) |
| DH vs. PRVA: Which Stock Should Value Investors Buy Now? |
Investors interested in Medical Info Systems stocks are likely familiar with Definitive Healthcare Corp. (DH) and Privia Health (PRVA). But which of these two stocks offers value investors a better bang for their buck right now? |
zacks.com |
2024-12-04 14:46:20 |
Czytaj oryginał (ang.) |
| Surging Earnings Estimates Signal Upside for Definitive Healthcare (DH) Stock |
Definitive Healthcare (DH) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions. |
zacks.com |
2024-11-25 15:21:18 |
Czytaj oryginał (ang.) |
| DH or PRVA: Which Is the Better Value Stock Right Now? |
Investors interested in Medical Info Systems stocks are likely familiar with Definitive Healthcare Corp. (DH) and Privia Health (PRVA). But which of these two stocks offers value investors a better bang for their buck right now? |
zacks.com |
2024-11-18 14:46:01 |
Czytaj oryginał (ang.) |
| Definitive Healthcare Corp. (DH)) Q3 2024 Earnings Call Transcript |
Definitive Healthcare Corp. (NASDAQ:DH ) Q3 2024 Earnings Conference Call November 7, 2024 5:00 PM ET Company Participants Matt Ruderman - Investor Relations Kevin Coop - Chief Executive Officer Richard Booth - Chief Financial Officer Conference Call Participants Jenny Shen - BTIG George Hill - Deutsche Bank Anna Kruszenski - Barclays Bank Operator Welcome to Definitive Healthcare's Q3 2024 Earnings Call. Later we will conduct a question-and-answer session. |
seekingalpha.com |
2024-11-10 10:50:27 |
Czytaj oryginał (ang.) |
| Definitive Healthcare Corp. (DH) Beats Q3 Earnings and Revenue Estimates |
Definitive Healthcare Corp. (DH) came out with quarterly earnings of $0.10 per share, beating the Zacks Consensus Estimate of $0.08 per share. This compares to earnings of $0.09 per share a year ago. |
zacks.com |
2024-11-07 21:10:51 |
Czytaj oryginał (ang.) |
| Definitive Healthcare Reports Financial Results for Third Quarter Fiscal Year 2024 |
Third quarter revenue exceeded guidance, and the Company announced a $100 million repurchase authorization Third quarter revenue exceeded guidance, and the Company announced a $100 million repurchase authorization |
globenewswire.com |
2024-11-07 18:05:00 |
Czytaj oryginał (ang.) |
| DH vs. GEHC: Which Stock Is the Better Value Option? |
Investors interested in Medical Info Systems stocks are likely familiar with Definitive Healthcare Corp. (DH) and GE HealthCare Technologies (GEHC). But which of these two stocks presents investors with the better value opportunity right now? |
zacks.com |
2024-10-29 14:40:30 |
Czytaj oryginał (ang.) |
| Definitive Healthcare launches Monocl Conferences to improve conference planning and participation for biopharma and medtech organizations |
Monocl Conferences equips life science organizations with an intuitive solution to enhance conference planning and KOL engagement Monocl Conferences equips life science organizations with an intuitive solution to enhance conference planning and KOL engagement |
globenewswire.com |
2024-10-17 13:05:00 |
Czytaj oryginał (ang.) |
| Definitive Healthcare launches predictive analytics solution that empowers healthcare organizations to prepare and plan for future market conditions |
Market Forecast equips providers with three, five, and 10-year market trend projections to strengthen strategic planning around future demand and growth opportunities Market Forecast equips providers with three, five, and 10-year market trend projections to strengthen strategic planning around future demand and growth opportunities |
globenewswire.com |
2024-10-10 13:05:00 |
Czytaj oryginał (ang.) |
| Irenic Capital Management LP's Strategic Acquisition in Definitive Healthcare Corp |
On September 30, 2024, Irenic Capital Management LP (Trades, Portfolio) made a significant addition to its investment portfolio by acquiring 6,413,185 shares of Definitive Healthcare Corp (DH, Financial). This transaction, executed at a price of $4.47 per share, marks a substantial increase in the firm's holdings in the healthcare sector, reflecting a strategic move to bolster its position in this industry. |
gurufocus.com |
2024-10-04 04:03:50 |
Czytaj oryginał (ang.) |
| INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Definitive Healthcare Corp. (DH) on Behalf of Investors |
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (NASDAQ: DH) investors concerning the Company's possible violations of federal securities laws. On July 30, 2024, Definitive Healthcare disclosed that it took a $363.6 million goodwill impairment, and that as a result the Company was reducing its 2024 fiscal year guidance. On this news, Definitive Healthcare's stock price f. |
businesswire.com |
2024-09-03 21:55:00 |
Czytaj oryginał (ang.) |
| Definitive Healthcare to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference |
FRAMINGHAM, Mass., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Chief Financial Officer, Rick Booth, will present at the Morgan Stanley 22nd Annual Global Healthcare Conference. |
globenewswire.com |
2024-08-29 20:05:00 |
Czytaj oryginał (ang.) |
| Definitive Healthcare launches powerful consumer analytics and activation solution to more industries with Population Intelligence expansion |
Population Intelligence empowers businesses to improve marketing campaigns and digital advertising performance with combined clinical and consumer insights Population Intelligence empowers businesses to improve marketing campaigns and digital advertising performance with combined clinical and consumer insights |
globenewswire.com |
2024-08-27 13:15:00 |
Czytaj oryginał (ang.) |
| Definitive Healthcare: Poor Near-Term Outlook, But New CEO May Change Things |
DH remains a hold rating due to its poor near-term outlook and recent results. 2Q24 results show decelerating growth, client count decline, and an elongated sales cycle. New CEO Kevin Coop could be a game changer, but there is no reason to invest in DH at this point. |
seekingalpha.com |
2024-08-19 16:12:42 |
Czytaj oryginał (ang.) |
| Definitive Healthcare Corp. (DH) Q2 2024 Earnings Call Transcript |
Definitive Healthcare Corp. (NASDAQ:DH ) Q2 2024 Earnings Conference Call August 5, 2024 5:00 PM ET Company Participants Matt Ruderman - Investor Relations Kevin Coop - Chief Executive Officer Rick Booth - Chief Financial Officer Conference Call Participants Saket Kalia - Barclays Craig Hettenbach - Morgan Stanley Joe Vruwink - Baird David Grossman - Stifel Matt Shea - Needham & Company Hanna Lee - Bank of America John McCary - Raymond James Jared Haase - William Blair Operator Welcome to Definitive Healthcare's Q2 2024 Earnings Call. At this time, all participants are in a listen-only mode. |
seekingalpha.com |
2024-08-06 02:50:08 |
Czytaj oryginał (ang.) |
| Definitive Healthcare Corp. (DH) Meets Q2 Earnings Estimates |
Definitive Healthcare Corp. (DH) came out with quarterly earnings of $0.09 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.08 per share a year ago. |
zacks.com |
2024-08-05 22:55:44 |
Czytaj oryginał (ang.) |
| Definitive Healthcare Reports Financial Results for Second Quarter Fiscal Year 2024 |
FRAMINGHAM, Mass., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter ended June 30, 2024. |
globenewswire.com |
2024-08-05 20:05:00 |
Czytaj oryginał (ang.) |
| Definitive Healthcare Announces Timing of Its Second Quarter 2024 Financial Results Conference Call and Webcast |
FRAMINGHAM, Mass., July 22, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its second quarter ended June 30, 2024, on Monday, August 5, 2024 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company's financial results. |
globenewswire.com |
2024-07-22 20:05:00 |
Czytaj oryginał (ang.) |